Biotech · Private company
STCube, Inc.
Track this companyFree. Adds STCube, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- hSTC810 400 mg + PaclitaxelPhase 2 · Extensive Stage Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- hSTC810 800 mg + PaclitaxelPhase 2 · Extensive Stage Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- hSTC810Phase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A Study of hSTC810 in Combination With Paclitaxel in Relapsed or Refractory Extensive Stage Small Cell Lung CancerPHASE1_PHASE2 · TERMINATED · started Feb 13, 2024ClinicalTrials.gov NCT06016270 · fetched Nov 12, 2026
- A Study of hSTC810 With Advanced/Metastatic Solid Tumors (STCUBE-001)PHASE1 · COMPLETED · started Apr 18, 2022ClinicalTrials.gov NCT05231746 · fetched Nov 12, 2026